Improvement and influencing factors of blood pressure control by nephrologist referral in chronic kidney disease patients in China: a cohort study

被引:4
|
作者
Wang, Li-Yan [1 ]
Yin, Dao-Xin [1 ]
Zhang, Dong-Liang [1 ]
Xu, Rui [1 ]
Cui, Wen-Ying [1 ]
Liu, Wen-Hu [1 ]
机构
[1] Capital Med Univ, Fac Kidney Dis, Affiliated Beijing Friendship Hosp, Dept Nephrol, Beijing 100050, Peoples R China
关键词
Chronic kidney disease; Hypertension; Blood pressure control; Antihypertensive treatment; SYSTOLIC HYPERTENSION; CARDIOVASCULAR EVENTS; ARTERIAL STIFFNESS; MANAGEMENT; PREVALENCE; TARGET; RISK; ALBUMINURIA; PROTEINURIA; PROTECTION;
D O I
10.1007/s11255-012-0332-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Hypertension is an independent risk factor for mortality in chronic kidney disease (CKD) and is suboptimally controlled worldwide. Therefore, this study aimed to examine the rate of BP control and the main barriers to achieving target BP, according to K/DOQI guidelines, in China. We performed a single-center, prospective cohort study. Two hundred and sixty CKD patients were referred by general physicians to nephrologists, and their BP was treated in accordance with K/DOQI guidelines for a 1-year follow-up. We evaluated improvement of BP target achievement and factors affecting BP control. We defined "not-at-goal" as persistence of systolic BP a parts per thousand yen 130 mmHg and/or diastolic BP a parts per thousand yen 80 mmHg after 1 year. The BP decreased from 138 +/- A 12/84 +/- A 7 mmHg at baseline to 124 +/- A 13/73 +/- A 7 mmHg after 1 year. The rate of achieving the BP goal (< 130/80 mmHg) increased from 25.4 to 61.5 %. The decrease in BP was associated with a significant reduction of proteinuria (median, 0.14 vs 0.06 g/24 h; P < 0.05). Logistic regression analysis identified proteinuria levels a parts per thousand yen1.0 g/24 h (odds ratio [OR]: 5.21; 95 % confidence interval [CI]: 1.37-19.77) and high basal systolic BP (OR: 2.17; 95 % CI: 1.25-3.77) and diastolic BP (OR: 6.62; 95 % CI: 2.03-21.60) as independent predictors of not-at-goal BP. Higher educational level was independently associated with at-goal BP (OR: 0.21; 95 % CI: 0.06-0.78). In CKD patients, BP control is poor when managed by general physicians and may be improved after nephrologist referral. High basal BP and proteinuria levels a parts per thousand yen1.0 g/24 h are the main barriers that preclude the optimal control of BP.
引用
收藏
页码:1345 / 1353
页数:9
相关论文
共 50 条
  • [21] Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease
    Bakris, George
    Chen, Cindy
    Campbell, Alicia K.
    Ashton, Veronica
    Haskell, Lloyd
    Singhal, Mukul
    AMERICAN JOURNAL OF HYPERTENSION, 2024, 37 (06) : 438 - 446
  • [22] Management and control of hypertension and proteinuria in patients with advanced chronic kidney disease under nephrologist care or not: data from the AVENIR study (AVantagE de la Nephroprotection dans l'Insuffisance Renale)
    Thilly, Nathalie
    Boini, Stephanie
    Kessler, Michele
    Briancon, Serge
    Frimat, Luc
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (03) : 934 - 939
  • [23] Blood Pressure Control During Chronic Kidney Disease Progression
    Lee, Seulbi
    Oh, Hyung Jung
    Lee, Eun-Kyung
    Lee, Oesook
    Ha, Eunhee
    Kim, Seung-Jung
    Kang, Duk-Hee
    Choi, Kyu Bok
    Ryu, Dong-Ryeol
    AMERICAN JOURNAL OF HYPERTENSION, 2017, 30 (06) : 610 - 616
  • [24] Association of continuity of care with blood pressure control in patients with chronic kidney disease and hypertension
    Khanam, Masuma A.
    Kitsos, Alex
    Stankovich, Jim
    Castelino, Ronald
    Jose, Matthew
    Peterson, Gregory M.
    Wimmer, Barbara
    Zaidi, Tabish Razi
    Radford, Jan
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2019, 48 (05) : 300 - 306
  • [25] Effect of telmisartan on blood pressure control and kidney function in hypertensive, proteinuric patients with chronic kidney disease
    Rysavá, R
    Tesar, V
    Merta, M
    BLOOD PRESSURE MONITORING, 2005, 10 (04) : 207 - 213
  • [26] Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease
    de Pinho, Natalia Alencar
    Levin, Adeera
    Fukagawa, Masafumi
    Hoy, Wendy E.
    Pecoits-Filho, Roberto
    Reichel, Helmut
    Robinson, Bruce
    Kitiyakara, Chagriya
    Wang, Jinwei
    Eckardt, Kai-Uwe
    Jha, Vivekanand
    Oh, Kook-Hwan
    Sola, Laura
    Eder, Susanne
    de Borst, Martin
    Taal, Maarten
    Feldman, Harold I.
    Stengel, Benedicte
    Djurdjev, Ognjenka
    Tang, Mila
    Fujii, Naohiki
    Maruyama, Shoichi
    Imaizumi, Takahiro
    Zhang, Jianzhen
    Wang, Zaimin
    Healy, Helen G.
    Massy, Ziad A.
    Combe, Christian
    Laville, Maurice
    Lopes, Antonio
    Pisoni, Ronald
    Bieber, Brian
    Tu, Charlotte
    Sangthawan, Pornpen
    Pichaiwong, Warangkana
    Klyprayong, Pinkaew
    Orlandi, Paula
    Townsend, Raymond
    Go, Alan
    Zhang, Luxia
    Kumar, Vivek
    Yadav, Ashok Kumar
    Baid-Agrawal, Seema
    Ahn, Curie
    Chae, Dong Wan
    Han, Seung Hyeok
    Rios, Pablo G.
    Gadola, Liliana
    Lamadrid, Veronica
    Leierer, Johannes
    KIDNEY INTERNATIONAL, 2019, 96 (04) : 983 - 994
  • [27] Association of Intensive Blood Pressure Control and Kidney Disease Progression in Nondiabetic Patients With Chronic Kidney Disease A Systematic Review and Meta-analysis
    Tsai, Wan-Chuan
    wu, Hon-Yen
    Peng, Yu-Sen
    Yang, Ju-Yeh
    Chen, Hung-Yuan
    Chiu, Yen-Ling
    Hsu, Shih-Ping
    Ko, Mei-Ju
    Pai, Mei-Fen
    Tu, Yu-Kang
    Hung, Kuan-Yu
    Chien, Kuo-Liong
    JAMA INTERNAL MEDICINE, 2017, 177 (06) : 792 - 799
  • [28] Hospital specific factors affect quality of blood pressure treatment in chronic kidney disease
    van Zuilen, A. D.
    Blankestijn, P. J.
    van Buren, M.
    ten Dam, M. A. G. J.
    Kaasjager, K. A. H.
    Ligtenberg, G.
    Sijpkens, Y. W. J.
    Sluiter, H. E.
    van de Ven, P. J. G.
    Vervoort, G.
    Vleming, L.
    Bots, M. L.
    Wetzels, J. F. M.
    NETHERLANDS JOURNAL OF MEDICINE, 2011, 69 (05) : 229 - 236
  • [29] Blood pressure in children with chronic kidney disease: lessons learned from the Chronic Kidney Disease in Children Cohort Study
    Wilson, Amy C.
    Flynn, Joseph T.
    PEDIATRIC NEPHROLOGY, 2020, 35 (07) : 1203 - 1209
  • [30] Blood pressure in children with chronic kidney disease: lessons learned from the Chronic Kidney Disease in Children Cohort Study
    Amy C. Wilson
    Joseph T. Flynn
    Pediatric Nephrology, 2020, 35 : 1203 - 1209